About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ccr4tm1Pwr
targeted mutation 1, Christine Power
MGI:2136258
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ccr4tm1Pwr/Ccr4tm1Pwr B6.129P2-Ccr4tm1Pwr MGI:5008732
hm2
Ccr4tm1Pwr/Ccr4tm1Pwr involves: 129P2/OlaHsd * C57BL/6 MGI:2660706


Genotype
MGI:5008732
hm1
Allelic
Composition
Ccr4tm1Pwr/Ccr4tm1Pwr
Genetic
Background
B6.129P2-Ccr4tm1Pwr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ccr4tm1Pwr mutation (1 available); any Ccr4 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• in cardiac grafts

hematopoietic system
• in cardiac grafts




Genotype
MGI:2660706
hm2
Allelic
Composition
Ccr4tm1Pwr/Ccr4tm1Pwr
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ccr4tm1Pwr mutation (1 available); any Ccr4 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• in vitro, homozygotes display normal Th2 and Th1 cell differentiation relative to wild-type mice
• in an OVA-induced model of airway inflammation, homozygotes display normal Th2-associated bronchial hyperreactivity in response to inhaled methacholine after OVA priming and intranasal challenge with saline, with no differences in OVA-induced eosinophilia in BALF and lung tissue, in total cell count or individual leukocyte populations in BALF, or in OVA-specific Ig titers relative to wild-type mice
• after A. fumigatus infection in the bronchoalveolar lavage
• after A. fumigatus infection in the bronchoalveolar lavage
• at 24 hrs after high dose LPS treatment, homozygotes show a reduction in the number of lymphocytes in the peritoneal lavage relative to wild-type mice
• at 24 hrs after high dose LPS treatment, homozygotes display significantly fewer macrophages in the peritoneal lavage, with reduced numbers of CD11b+ and CD14+ cells and an absence or severely reduced number of F4/80-expressing cells relative to wild-type mice
• after A. fumigatus infection in the bronchoalveolar lavage
• 30 days after A. fumigatus infection
• 3 and 7 days after A. fumigatus infection
• 3 days after A. fumigatus infection
• unexpectedly, mutant splenocytes show no chemotactic response to human or mouse chemokine (C-C motif) ligand 3 (also known as macrophage inflammatory protein MIP-1alpha)
• in contrast, the response of mutant splenocytes to human RANTES is similar to that observed in wild-type mice
• at 3 hrs after injection of a high dose of LPS (60 mg/kg), homozygotes show a significant decrease in serum MIP-alpha levels relative to wild-type mice, suggesting a possible macrophage defect
• 3 days after A. fumigatus infection
• at 3 hrs after injection of a high dose of LPS (60 mg/kg), homozygotes show a 6-fold decrease in serum IL-1beta levels relative to wild-type mice
• in contrast, IL-6 production remains unchanged relative to wild-type mice
• 30 days after A. fumigatus infection
• 3 days after A. fumigatus infection
• 30 days after A. fumigatus infection
• 30 days after A. fumigatus infection
• 3 days after A. fumigatus infection
• 30 days after A. fumigatus infection
• 3 days after A. fumigatus infection
• in response to a high LPS dose (60 mg/kg), homozygotes fail to induce significant levels of serum TNF, whereas wild-type mice show a sharp increase in serum TNF levels at 1.5 hrs which return to baseline by 4 hrs after LPS treatment
• in vitro, peritoneal lavage cells from naive homozygotes produce significantly lower TNF levels when cultured for 18 hrs in the presence of 1 g/ml LPS relative to cells from naive wild-type mice (107 11 versus 201 18 pg/ml, respectively)
• after A. fumigatus infection
• in response to high doses of LPS (60-120 mg/kg), homozygotes show no differences in initial platelet mobilization but display milder signs of shivering and lethargy than wild-type during the first few hours after LPS injection, with platelet counts returning to normal at day 5 and 93% of homozygotes still alive on day 6, whereas all wild-type die between 2 and 4 days after treatment
• in response to a low dose of LPS (1 g) plus 8 mg of D-gal, 9 of 12 homozygotes survive whereas the majority of wild-type (11 of 12) die; following treatment with 4 g of LPS plus D-gal, all homozygotes tested die with a 6-hr delay relative to wild-type mice
• 7 days after Aspergillus fumigatus infection, mice clear fungal spores from the lungs; increased neutrophil, eosinophil, and macrophage numbers in the bronchoalveolar lavage (BAL); increased early airway resistance; increased early levels of TNFalpha, IFN-gamma, IL4, IL5, and IL10 in the BAL; and increased early IgE and IgG1 levels compared with wild-type mice
• 3 days after A. fumigatus infection airway resistance is increased compared to in wild-type mice
• 30 days after A. fumigatus infection airway resistance is decreased compared to in wild-type mice

respiratory system
• 30 days after A. fumigatus infection
• 3 days after A. fumigatus infection

hematopoietic system
• after A. fumigatus infection in the bronchoalveolar lavage
• after A. fumigatus infection in the bronchoalveolar lavage
• at 24 hrs after high dose LPS treatment, homozygotes show a reduction in the number of lymphocytes in the peritoneal lavage relative to wild-type mice
• at 24 hrs after high dose LPS treatment, homozygotes display significantly fewer macrophages in the peritoneal lavage, with reduced numbers of CD11b+ and CD14+ cells and an absence or severely reduced number of F4/80-expressing cells relative to wild-type mice
• after A. fumigatus infection in the bronchoalveolar lavage
• 30 days after A. fumigatus infection
• 3 and 7 days after A. fumigatus infection
• 3 days after A. fumigatus infection
• unexpectedly, mutant splenocytes show no chemotactic response to human or mouse chemokine (C-C motif) ligand 3 (also known as macrophage inflammatory protein MIP-1alpha)
• in contrast, the response of mutant splenocytes to human RANTES is similar to that observed in wild-type mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory